investorscraft@gmail.com

Stock Analysis & ValuationVivos Therapeutics, Inc. (VVOS)

Previous Close
$0.81
Sector Valuation Confidence Level
High
Valuation methodValue, $Upside, %
Artificial intelligence (AI)20.262410
Intrinsic value (DCF)113.6813983
Graham-Dodd Methodn/a
Graham Formulan/a

Company Information

9137 Ridgeline Boulevard
Highlands Ranch, CO 80129
United States
Phone: 866 908 4867
Industry: Medical - Devices
Sector: Healthcare
CEO: R. Kirk Huntsman
Full Time Employees: 109

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. Vivos Therapeutics also offers VivoScore Program, a screening and home sleep test in adults and children. The company markets and sells its Vivos System to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Highlands Ranch, Colorado.

HomeMenuAccount